Literature DB >> 1964796

Association of hst gene expression with metastatic phenotype in mouse mammary tumors.

A Murakami1, H Tanaka, A Matsuzawa.   

Abstract

From the pregnancy-dependent mouse mammary tumor TPDMT-4, four autonomous sublines were established after its independent progression under different conditions. Despite their similar growth rates in inguinal fat pads, three sublines formed lung metastases, and one did not when they were injected i.v. into mice as a single cell suspension. The TPDMT-4 tumor and the nonmetastatic subline expressed mRNA for the orf gene of mouse mammary tumor virus, whereas all metastatic sublines did not. This suggested that the loss of its expression may have been a prerequisite for the progression toward metastatic ability. To identify the gene(s) participating in the generation and the progression of TPDMT-4, the expression of 23 different oncogenes was analyzed. The expression of int-2 was detected in TPDMT-4 and in all sublines, indicating that TPDMT-4 was generated by activation of this gene, whereas hst expression occurred only in the metastatic sublines. These results demonstrated that the hst gene may contribute to tumor progression from a nonmetastatic to a metastatic phenotype in the mouse mammary tumor system.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1964796

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  5 in total

1.  Loss of basal cell phenotype with acquisition of lung-colonizing capability in mouse mammary tumors.

Authors:  A Tsubura; T Inui; S Morii; S H Dairkee; T Oikawa; A Matsuzawa
Journal:  Breast Cancer Res Treat       Date:  1991 Jan-Feb       Impact factor: 4.872

2.  Cloning and identification of genes differentially expressed in metastatic and non-metastatic rat rhabdomyosarcoma cell lines.

Authors:  L Daigneault; R Beaulieu; M Filion; L Gaboury; A Royal; F Babaï
Journal:  Clin Exp Metastasis       Date:  1995-09       Impact factor: 5.150

3.  Adenovirus-mediated transfer of the HST-1 (FGF4) gene induces increased levels of platelet count in vivo.

Authors:  H Sakamoto; T Ochiya; Y Sato; M Tsukamoto; H Konishi; I Saito; T Sugimura; M Terada
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

Review 4.  Anti-invasion drugs.

Authors:  R B Dickson; M D Johnson; M Maemura; J Low
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

5.  Cell transformation by kFGF requires secretion but not glycosylation.

Authors:  F Fuller-Pace; G Peters; C Dickson
Journal:  J Cell Biol       Date:  1991-10       Impact factor: 10.539

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.